CEP (Certificate of Suitability), Certification of suitability of European Pharmacopoeia monographs

-


The role of a Certificate of Suitability  is to certify the compliance of a material with the requirements laid down in the relevant monograph of the European Pharmacopoeia. Active pharmaceutical ingredients for which a Certificate of Suitability has been granted are suitable for use in medicinal products.
What is the Full form of abbreviation, CEP?

Certificate of Suitability to the monographs of the European Pharmacopoeia (or) Certificate of suitability of monographs of the European Pharmacopoeia (or) Certification of suitability of European Pharmacopoeia monographs

It is also informally referred to as Certificate of Suitability (COS)



What is a CEP?

It is the certificate which is issued by Certification of Substances Division of European Directorate for the Quality of Medicines (EDQM), when the manufacturer of a substance provides proof that the quality of the substance is suitably controlled by the relevant monographs of the European Pharmacopoeia.



For which substances, applications for the grant of CEPs can be submitted?

Applications for the grant of CEPs can be submitted to EDQM if monograph (general monograph and/or specific monograph) has been adopted by the European Pharmacopoeia for the following-

·                     Organic or inorganic substances (active or excipients), manufactured or extracted.

·                     Sterile Active Substances

·                     Substances produced by fermentation as indirect gene products, which are metabolites of microorganisms, irrespective of whether or not the microorganisms have been modified by traditional procedures or r-DNA technology

·                     Products with risk of transmitting agents of animal spongiform encephalopathies (TSE)

·                     Herbal Drugs and Herbal Drug Preparations

For which substances CEP is not granted?

·                     Direct gene products (proteins)

·                     Products obtained from human tissues

·                     Vaccines

·                     Blood products and preparations.

What are the Legislations which describe certification Procedure?


Directives 2001/82/EC and 2001/83/EC, as amended, of the European Council and of the Parliament.

Guidelines to be referred for preparing Dossier to obtain a CEP 






Note :  
1. Each of the above guideline corresponds to individual type of substances. For example, the first Guideline is to be referred for preparing dossier to obtain a CEP for an API.


Application form and template for QOS 
Link for Downloading Application form and template of QOS.

Note: Click on the hyperlinks in blue for application form and template of QOS to download them.

Online Database of Approved CEPs 
Link to Online Databases of Approved CEPs 

Registration Fees
Registration fees for various New CEP Applications 

 Deficiencies
 Link to top 10 deficiencies in New Applications for grant of CEPs 

Recognition of CEPs- CEPs are recognised by all the member countries of the European Union and also   other Countries like Canada, Australia, New Zealand, Tunisia and Morocco.
 
Advantages of CEPs-

·                      It is valid for 5 Years.

·                     An API manufacturer need not file an ASMF/EDMF in all the member countries involved in DCP/MRP Procedures if the manufacturer has obtained CEP for that specific API. Sending a Copy of CEP will do.

·                     Centralised evaluation of Dossier by only one agency i.e EDQM.



Comments

  1. Adam Mill17 January 2020 at 11:37

    If you use Top IBM Exams brainDumps study material for exam, you will pass the exam for sure!

    ReplyDelete

Post a Comment

Popular posts from this blog

Introduction to Regulatory Affairs & Explanation of terms related to Regulatory Affairs

-
Introduction to Regulatory Affairs What is Regulatory Affairs? Regulatory Affairs is a profession within regulated industries namely-pharmaceuticals, medical devices, energy and banking . It has specific meaning within healthcare industries namely- pharmaceuticals, medical devices, biologics and functional foods. (In this blog I am going to deal about Regulatory Affairs related to pharmaceuticals meant for human use). Regulatory Affairs in the pharma industry may be defined as " The interface between the pharmaceutical company and the regulatory agencies across the world. "   In the above presentation, I am conveying the fact that -among all the departments of a pharma company Regulatory Affairs Department acts as the interface between the pharmaceutical company and the regulatory agencies across the world. Regulatory agency in the present context may be defined as " The competent government agency which is responsible for ensuring that medici
Read more

GAP or Findings in Regulatory Compliance

-
Image
Gap Analysis for Regulatory Compliance Gap analysis is an effective tool to determine the deficiencies in implementation of any procedure or regulatory guidance. If you are preparing for any regulatory inspection then gap analysis can help in compliance with regulatory guidelines. A comparison between the regulatory guidance and current practices is known as gap analysis. Gap analysis should be done for all SOPs, validation procedures and other activities to find out the possibilities of improvement. The room for improvement is identified by gap analysis. Therefore, make the checklists of the document you want to analyze and then check the actual working against the checklist. Gap analysis should also be done for regulatory guidelines like data integrity, risk assessment, good manufacturing practices, good laboratory practices, good documentation practices, good distribution practices etc to eliminate the possible non-compliances. Gap analysis may be carried out for specifi
Read more

Artificial Intelligence in the Medical Robotics Industry – Current Applications

-
AI applications for healthcare are becoming more common for white-collar automation and diagnostics . However, medical robotics is an area that may be marginally underdeveloped. This is likely because of regulations concerning automated surgery. In this article, I cover how AI software is finding its way into medical robotics now and how it might in the future with more investment and when the density of AI talent at medical robotics companies increases. Specifically, we explore: AI for Medical Robotics – What’s Possible, and What’s Being Used by healthcare clients right now. We found little to no case studies showing a health network or hospital’s success with AI-based medical robotics. The State of AI at Medical Robotics Vendors – the AI talent at medical robotics companies and a discussion of how to vet a vendor on whether or not its software is truly leveraging AI We begin our exploration of AI applications for medical robotics with an overview of the po
Read more